loading
Schlusskurs vom Vortag:
$8.76
Offen:
$8.9
24-Stunden-Volumen:
27,165
Relative Volume:
0.22
Marktkapitalisierung:
$44.27M
Einnahmen:
$7.97M
Nettoeinkommen (Verlust:
$-75.74M
KGV:
-0.3459
EPS:
-24.2853
Netto-Cashflow:
$-85.33M
1W Leistung:
-7.89%
1M Leistung:
+16.50%
6M Leistung:
-64.92%
1J Leistung:
-36.60%
1-Tages-Spanne:
Value
$8.25
$8.98
1-Wochen-Bereich:
Value
$8.25
$9.44
52-Wochen-Spanne:
Value
$3.76
$46.80

Aligos Therapeutics Inc Stock (ALGS) Company Profile

Name
Firmenname
Aligos Therapeutics Inc
Name
Telefon
(800) 466-6059
Name
Adresse
ONE CORPORATE DR., 2ND FLOOR, SOUTH SAN FRANCISCO
Name
Mitarbeiter
70
Name
Twitter
Name
Nächster Verdiensttermin
2024-11-06
Name
Neueste SEC-Einreichungen
Name
ALGS's Discussions on Twitter

Vergleichen Sie ALGS mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
ALGS
Aligos Therapeutics Inc
8.33 55.83M 7.97M -75.74M -85.33M -24.29
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
468.07 120.60B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
558.78 60.80B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
327.03 42.87B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
596.39 36.23B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
305.37 31.54B 3.81B -644.79M -669.77M -6.24

Aligos Therapeutics Inc Stock (ALGS) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2024-08-19 Eingeleitet H.C. Wainwright Buy
2023-01-06 Hochstufung Jefferies Hold → Buy
2023-01-06 Hochstufung Piper Sandler Neutral → Overweight
2022-03-23 Herabstufung Piper Sandler Overweight → Neutral
2022-01-07 Herabstufung JP Morgan Overweight → Neutral
2022-01-06 Herabstufung Jefferies Buy → Hold
2021-09-09 Eingeleitet SVB Leerink Outperform
2021-05-17 Fortgesetzt Piper Sandler Overweight
2020-11-10 Eingeleitet Cantor Fitzgerald Overweight
2020-11-10 Eingeleitet JP Morgan Overweight
2020-11-10 Eingeleitet Jefferies Buy
2020-11-10 Eingeleitet Piper Sandler Overweight
Alle ansehen

Aligos Therapeutics Inc Aktie (ALGS) Neueste Nachrichten

pulisher
06:53 AM

What data driven models say about Aligos Therapeutics Inc.’s futureFree Swing Trade With Risk Management - Newser

06:53 AM
pulisher
06:01 AM

Volatility clustering patterns for Aligos Therapeutics Inc.High Reward Investment Strategy for Beginners - Newser

06:01 AM
pulisher
04:44 AM

Real time breakdown of Aligos Therapeutics Inc. stock performanceFree Weekly Potential Breakout Stock List - Newser

04:44 AM
pulisher
04:28 AM

Why Aligos Therapeutics Inc. stock attracts strong analyst attentionIntraday Price Action Forecast Planner - Newser

04:28 AM
pulisher
12:53 PM

Is This the Dip to Buy in Aligos Therapeutics Inc.Real-Time Trade Insights Spark Market Reactions - metal.it

12:53 PM
pulisher
Jul 28, 2025

Is Aligos Therapeutics Inc. stock overvalued or undervaluedInvest confidently with expert support - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 28, 2025

Statistical indicators supporting Aligos Therapeutics Inc.’s strengthMarket Sentiment Tracker with Smart Alerts - Newser

Jul 28, 2025
pulisher
Jul 28, 2025

How does Aligos Therapeutics Inc. generate profit in a changing economyOverwhelming profit margins - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 28, 2025

Aligos Therapeutics Inc. Stock Chart Analysis: Bullish or Bearish Pattern Forming Predictive Analytics for Equity Growth Potential - Newser

Jul 28, 2025
pulisher
Jul 28, 2025

News impact scoring models applied to Aligos Therapeutics Inc. Daily Stock Watch Summary with Key Insights - Newser

Jul 28, 2025
pulisher
Jul 28, 2025

What data driven models say about Aligos Therapeutics Inc.’s future Forecast Model for Intraday Buy Signals - Newser

Jul 28, 2025
pulisher
Jul 28, 2025

What are the latest earnings results for Aligos Therapeutics Inc.Unlock your portfolio’s hidden potential - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 27, 2025

What makes Aligos Therapeutics Inc. stock price move sharplyMaximize portfolio growth with expert advice - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

Is Aligos Therapeutics Inc. Stock a Smart Buy in 2025 Investment Analysis InsidePro Trader Stock Focus - Newser

Jul 27, 2025
pulisher
Jul 27, 2025

Aligos Therapeutics Inc. Stock Chart Analysis: Bullish or Bearish Pattern FormingFree Low-Risk Investment Plans - Newser

Jul 27, 2025
pulisher
Jul 27, 2025

Moving Average Trends for Aligos Therapeutics Inc. Stock: What They IndicateTrend Based Entry Alerts - Newser

Jul 27, 2025
pulisher
Jul 25, 2025

What analysts say about Aligos Therapeutics Inc. stockLightning-fast capital gains - PrintWeekIndia

Jul 25, 2025
pulisher
Jul 25, 2025

Will Aligos Therapeutics Inc. stock benefit from AI tech trendsSuperior returns - jammulinksnews.com

Jul 25, 2025
pulisher
Jul 24, 2025

Does Aligos Therapeutics Inc. stock pay reliable dividendsFree Stock Market Knowledge Sharing - jammulinksnews.com

Jul 24, 2025
pulisher
Jul 23, 2025

What drives Aligos Therapeutics Inc. stock priceMarket-leading profit generation - Autocar Professional

Jul 23, 2025
pulisher
Jul 23, 2025

Aligos Therapeutics Inc. Stock Analysis and ForecastFree Stock Market Forecast Reports - jammulinksnews.com

Jul 23, 2025
pulisher
Jul 23, 2025

Is Aligos Therapeutics Inc. a good long term investmentConsistent high-performance stocks - jammulinksnews.com

Jul 23, 2025
pulisher
Jul 22, 2025

How Aligos Therapeutics Inc. stock performs during market volatilityStrong Return Daily Alerts - Newser

Jul 22, 2025

Finanzdaten der Aligos Therapeutics Inc-Aktie (ALGS)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$76.47
price up icon 8.79%
$37.35
price up icon 0.78%
$103.91
price up icon 2.11%
$26.69
price down icon 2.84%
$110.32
price down icon 2.14%
biotechnology ONC
$305.37
price up icon 3.76%
Kapitalisierung:     |  Volumen (24h):